Document Type : Original Article


1 Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine Zagazing University, Zagazing, Egypt

2 Department of Pediatrics, Al-Jahra Hospital, Ministry of Health, Al-Jahra City, Kuwait


Colorectal Cancer (CRC) is the third most common cancer in Iranian men and the fourth most common cancer in women. Recent studies have shown that lncRNAs may also engage in remodeling the tumor microenvironment and tumor metastasis. A lncRNA called LBX2 antisense RNA 1 (LBX2-AS1) has been reported to exert crucial regulatory actions in various cancer. In this study, we evaluate the expression of LBX2-AS1gene in 30 colorectal cancer tumor samples. Gene expression was assessed by Real-time PCR method and the results were analyzed by 2^-DDct. relative expression of this gene in tumor samples compared to healthy samples showed a 1.4-fold increase in tumor samples. According to our findings in this study and the results of other studies, it can be concluded that this gene can be used as a therapeutic target.


1. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly
LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal
cancer statistics, 2020. CA: a cancer journal for clinicians. 2020
2. Vardanjani HM, Haghdoost A, Bagheri-Lankarani K, Hadipour M.
Estimation and projection of prevalence of colorectal cancer in
Iran, 2015–2020. Advanced biomedical research. 2018;7.
3. Bazzini AA, Johnstone TG, Christiano R, et al. Identification
of small ORFs in vertebrates using ribosome footprinting and
evolutionary conservation. Embo J. 2014;33(9):981-993.
4.Zhao CH, Bai XF, Hu XH. Knockdown of lncRNA XIST
inhibits hypoxia-induced glycolysis, migration and invasion
through regulating miR-381-3p/NEK5 axis in nasopharyngeal
carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(5):2505-
5. Zhang M, Wang F, Xiang Z, Huang T, Zhou WB. LncRNA XIST
promotes chemoresistance of breast cancer cells to doxorubicin
by sponging miR-200c-3p to upregulate ANLN. Clin Exp
Pharmacol Physiol. 2020;47(8):1464-1472.
6. Dong Z, Liu H, Zhao G. Long noncoding RNA SNHG6
promotesproliferation and inhibits apoptosis in non-small cell
lung cancer cells by regulating miR-490-3p/RSF1 axis. Cancer
Biother Radiopharm. 2020;35(5):351-361.
7. Wang Y, Nie H, He X, et al. The emerging role of super
enhancerderived noncoding RNAs in human cancer.
Theranostics. 2020;10(24):11049-11062.
8. Wang Y, Zhao Y, Zhang X, Zhang A, Ma J. Long noncoding RNA
LBX2-AS1 drives the progression of hepatocellular carcinoma
by sponging microRNA-384 and thereby positively regulating
IRS1 expression. Pathol Res Pract. 2020;216(4):152903.
9. Zhang Y, Chen W, Pan T, Wang H, Zhang Y, Li C. LBX2-AS1 is
activated by ZEB1 and promotes the development of esophageal
squamous cell carcinoma by interacting with HNRNPC to
enhance the stability of ZEB1 and ZEB2 mRNAs. Biochem
Biophys Res Commun. 2019;511(3):566-572.
10. Yang Z, Dong X, Pu M, et al. LBX2-AS1/miR-219a-2-3p/FUS/
LBX2 positive feedback loop contributes to the proliferation of
gastric cancer. Gastric Cancer. 2019;23(3):449-463.
12. Tang LX, Su SF, Wan Q, He P, Xhang Y, Cheng XM. Novel
long non-coding RNA LBX2-AS1 indicates poor prognosis
and promotes cell proliferation and metastasis through Notch
signaling in non-small cell lung cancer. Eur Rev Med Pharmacol
Sci. 2019;23(17):7419-7429.
13. Huarte M, Guttman M, Feldser D, et al. A large intergenic
RNA induced by p53 mediates global gene repression in
the p53 response. Cell. 2010;142(3):409-419.
14. Ou C, Sun Z, Zhang H, et al. SPLUNC1 reduces the inflammatory
response of nasopharyngeal carcinoma cells infected with the
EB virus by inhibiting the TLR9/NF-kappaB pathway. Oncol
Rep. 2015;33(6):2779-2788.
15. Li Y, Zhao C, Yu Z, et al. Low expression of miR-381 is a
favorite prognosis factor and enhances the chemosensitivity of
osteosarcoma. Oncotarget. 2016;7(42):68585-68596.
16. Dang W, Qin Z, Fan S, et al. miR-1207-5p suppresses lung
cancer growth and metastasis by targeting CSF1. Oncotarget.
17. Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server
for cancer and normal gene expression profiling and interactive
analyses. Nucleic Acids Res. 2017;45(w1):W98-W102.
18. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer
prevalence for 27 sites in the adult population in 2008. Int J
Cancer. 2013;132(5):1133-1145.
19. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China,
2015. CA Cancer J Clin. 2016;66(2):115-132.
20. DeSantis CE, Miller KD, Dale W, et al. Cancer statistics for adults
aged 85 years and older, 2019. CA Cancer J Clin. 2019;69(6):
21. Atianand MK, Caffrey DR, Fitzgerald KA. Immunobiology long noncoding RNAs. Annu Rev Immunol. 2017;35:177-198.
22. Thomson DW, Dinger ME. Endogenous microRNA sponges:
evidence and controversy. Nat Rev Genet. 2016;17(5):272-283.
23. Ponting CP, Oliver PL, Reik W. Evolution and functions of long
noncoding RNAs. Cell. 2009;136(4):629-641.
24. Ou C, Li G. Long non-coding RNA TUG1: a novel therapeutic
target in small cell lung cancer. J Thorac Dis. 2017;9(7):
25. He X, Li S, Yu B, et al. Up-regulation of LINC00467 promotes
the tumourigenesis in colorectal cancer. J Cancer. 2019;10(25):
26. Zhuo W, Hu D, Chen X, Zhang T. LINC01638 silencing inhibits
cancer cell proliferation in colorectal adenocarcinoma through
interaction with RUNX2. Mol Med Rep. 2019;19(6):5275-5280.
27. Wang N, Yu Y, Xu B, Zhang M, Li Q, Miao L. Pivotal prognostic
and diagnostic role of the long noncoding RNA colon cancer
associated transcript 1 expression in human cancer (Review).
Mol Med Rep. 2019;19(2):771-782.
28. Ou C, Sun Z, He X, et al. Targeting YAP1/LINC00152/FSCN1
signaling axis prevents the progression of colorectal cancer. Adv
Sci (Weinh). 2020;7(3):1901380.